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Background: In April 2005, researchers based at the Medical Research Council Clinical Trials Unit, set out to involve
women affected by cervical cancer in a systematic review and meta-analysis of individual patient data to evaluate
treatments for this disease. Each of the women had previously been treated for cervical cancer. Following
completion of the meta-analysis, we aimed to evaluate the process of involvement from the researcher and
research partner perspective.
Methods: An advisory group was first established to give advice on recruiting, supporting and involving women and
led to efforts to recruit women to take part in the systematic review using different approaches. Evaluation of the
process and outcomes of the partnership between the systematic reviewers and the patients, in respect to what the
partnership achieved; what worked well and what were the difficulties; what was learned and the resource
requirements, took place during the conduct of the meta-analysis and again after completion of the project.
Results: Six women, each of whom had received treatments for cervical cancer, were recruited as Patient Research
Partners and five of these women subsequently took part in a variety of activities around the systematic review. They
attended progress meetings and all but one attended a meeting at which the first results of the review were presented
to all collaborators and gave feedback. Three of the women also became involved in a further related research project
which led to an editorial publication from the patient perspective and also participated, along with two lead researchers,
in the evaluation of the process and outcomes. While they were generally positive about the experience, one Patient
Research Partner questioned the extent of the impact patients could make to the systematic review process.
Conclusions: In general, researchers and patient research partners felt that they had learned a lot from the process and
considered it to have been a positive experience. The researchers felt that because of resource implications, patient
involvement in future systematic reviews would probably have to be prioritized to those in which the greatest impacts
could be achieved.
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Public and patient involvement in healthcare research
has been widely recognized and supported by commis-
sioning and funding bodies in the UK [1,2] and else-
where [3]. Moreover, involvement in systematic reviews
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reproduction in any medium, provided the orCochrane Collaboration [4] for some time, largely
through the Cochrane Consumer Network (http://
consumers.cochrane.org/) and consumer membership of
Cochrane Review Groups, with the aim of ensuring the
accessibility and relevance of Cochrane systematic
reviews to patients, caregivers and service users. How-
ever, there are relatively few reported case examples in
the medicalliterature that describe or evaluate patient or
public involvement in specific systematic reviews. In-
deed, despite extensive literature searches, a recent. This is an Open Access article distributed under the terms of the Creative
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only seven published examples, only two of which had
included a quantitative meta-analysis [6,7] of which
only one formally evaluated the effects of a treatment
intervention [7]. This review of patient and public in-
volvement in systematic reviews found that public
involvement had made five main contributions to
reviews, including refining the scope, identifying and
locating relevant studies, appraising the literature,
interpretation of the review findings, and writing the
reports [5].
In September 2004, we initiated a systematic review
and meta-analysis of chemoradiotherapy for the treat-
ment of women with cervical cancer which aimed to col-
lect and re-analyze individual patient data (IPD) from all
relevant, eligible randomized controlled trials (RCTs)
worldwide. At that time, the available evidence suggested
that survival was improved in women with cervical can-
cer if they received chemoradiotherapy. There were
some concerns among the clinical community, however,
regarding long-term side effects potentially associated
with this treatment. Therefore, we aimed to evaluate not
only the effect of chemoradiotherapy on survival, recur-
rence and spread of cervical cancer, but also on the
prevalence and severity of treatment-related side effects.
We were keen to involve women who had experienced
treatment for cervical cancer in the project, to inform
the discussion about the treatments involved and, in par-
ticular, how side effects might impact on women’s day-
to-day lives post treatment. We also wanted to gain a
better understanding of what might be considered ac-
ceptable in terms of side effects, assuming that a survival
advantage was confirmed. In addition to involving
patients in the systematic review process, we also aimed
to evaluate involvement with the aim of informing the
practice of patient involvement in future systematic
reviews conducted by our group and others. Results of
the systematic review and meta-analysis have been pub-
lished elsewhere [8].
Methods
Establishment of a Reference Group
Initially, we set up a small Reference Group, to provide
advice on the recruitment of women, provision of sup-
port and information, and on the activities they might
undertake. Members of this Group included two
gynecological cancer nurse specialists, the Consumer Li-
aison lead for the National Cancer Research Network,
two experts in consumer involvement in healthcare re-
search, the then CEO of Jo’s Trust (www.jostrust.org.uk)
and one former cervical cancer patient, who was already
known to the CEO of Jo’s Trust and who agreed to be
involved both in the Reference Group and also in the
systematic review.The first meeting of the Reference Group (April 2005)
led to the development of terms of reference and a
role description for patients who were to get involved
(Additional file 1) and to the term “Patient Research
Partners” to describe the role of the women. The group
also provided feedback and comments on a detailed in-
formation folder and accompanying workshop aimed at
describing systematic reviews and meta-analyses to the
Patient Research Partners once involved (Additional
file 2). Reference Group members also helped in recruit-
ing Patient Research Partners, both by approaching suit-
able women whom they knew and through the
development of a job description and advert. One fur-
ther meeting of the Reference Group was held in May
2007 to discuss progress and provide feedback.
Establishing a group of Patient Research Partners
One of the most successful methods used to recruit
women to be Patient Research Partners was the use of
personal approaches from individual Reference Group
members. In particular, approaches by the former patient
(who was also a Patient Research Partner) and the CEO
of Jo’s Trust. These direct approaches or recommenda-
tions led to recruitment of three women. The other most
successful route to recruiting women was by advertising
the opportunity to take part through CancerVoices
(http://opportunities.macmillan.org.uk/opportunities.aspx).
CancerVoices opportunities are distributed to people who
have been affected by cancer and who are interested in par-
ticipating in research projects and in sharing their experi-
ences. Two women were recruited via this route. Other
methods of recruitment, including sending information
about the opportunity to become involved to cervical or
gynecological cancer support groups across England, were
all unsuccessful. Six women, all of whom had been treated
for cervical cancer, were therefore recruited as Patient
Research Partners; however, one woman, who had
advanced disease, became too unwell to attend meetings
and subsequently died.
Patient research partner participation and contribution to
the IPD meta-analysis
Following the first meeting of the Patient Research
Partners (October 2005) they became involved in a
number of activities associated with the systematic re-
view, including providing feedback on the detailed infor-
mation folders; helping to trace contact details for trial
investigators; learning about data management and ana-
lysis and contributing to regular project newsletters.
Four Patient Research Partners attended the Collabora-
tors’ Meeting (May 2006), at which the first results of
the systematic review and meta-analysis were presented,
along with the clinicians and statisticians who had pro-
vided trial data for inclusion in the meta-analysis. The
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meeting due to family commitments, subsequently chose
to have no further involvement in the project.
Interim feedback from the remaining four Patient
Research Partners, both on their experiences of attend-
ing the Collaborators’ meeting as well as other aspects
of the project was sought (July 2006), resulting in
sections describing meta-analysis results and a glossary
of terms being drafted for the information folders and to
the development of a ‘key findings’ document aimed at
clinicians, researchers and patients.
The Patient Research Partners remained involved
throughout the period during which the main publica-
tion of the systematic review and meta-analysis was
being written (2007 to 2008). They provided input into
the lay summary for the Cochrane systematic review [9]
as well as taking part in discussions about potential
research on chemoradiotherapy side effects. It was
also planned to evaluate their involvement. During this
period, one of the women moved abroad and took no
further part in the project. In 2009, the researchers be-
came involved in a related research project based on a
Royal College of Radiologists audit of the effects of treat-
ment for cervical cancer, including associated side effects
[10]. The three remaining Patient Research Partners
agreed to write a joint editorial with the researchers, to
describe these side effects from a patient perspective
[11]. Throughout the course of the two related research
projects, six meetings were held approximately annually,
more frequently at the outset. Additional communica-
tion was largely by email.
Final evaluation of patient involvement
In August 2010, we set out to evaluate the experience
from both the Patient Research Partners and research-
ers perspectives. While this was not a prospectively
designed qualitative research project, we hoped to
learn from the experiences of the Patient Research
Partners and researchers to inform our future practice.
Initially the Patient Research Partners and the re-
searchers completed a short questionnaire that in-
cluded a series of open questions about reasons for
involvement; expectations, perceived benefits and chal-
lenges of involvement; the impact of involvement and
whether and how future meta-analyses should best in-
volve consumers. Following completion of the ques-
tionnaires, individual answers to each question were
first collated and any major themes emerging from the
responses were identified. A summary report was then
drafted and circulated to the respondents. Finally, a
meeting was held to further discuss the emerging
themes and, where necessary, to add clarity and detail
to the responses obtained in the individual question-
naires. Following the meeting, the summary report wasrevised in light of these discussions and circulated to
all to ensure that it reflected accurately the discussions
that had taken place.
Results
Five questionnaires (100 %) were completed, three
from the Patient Research Partners and two from the
researchers. Information from the completed question-
naires was supplemented with discussion at a follow-up
evaluation meeting and with feedback obtained from
four Patient Research Partners in June 2006. One
Research Partner, who had emigrated in 2008, did not
participate in the final evaluation, but provided detailed
feedback in 2006. A fifth Research Partner who with-
drew from the project in April 2006 did not participate
in either evaluation, and we were not able to ascertain
her reasons for leaving the project.
What were the motivations for Patient Research Partners
and researchers?
Patient research partner involvement in systematic review
and meta-analysis of IPD
In general, the researchers had wanted to find out
whether it was possible to properly involve patients in a
systematic review and meta-analysis based on individual
patient data and to better explain the process to people.
They were keen to involve patients and had tried to do
so in prior projects but with limited success due to diffi-
culties in recruiting, supporting and involving them ef-
fectively. However, for this project there was funding
“that allowed us to resource involvement properly” and
so the researchers had “been able to give it a lot more
thought; got more prepared”. The Patient Research
Partners thought the project sounded interesting. One
Patient Research Partner, who had previously conducted
systematic reviews as a researcher, thought that “it
would be interesting to be involved from a patient
perspective.”
Survivorship issues
Perhaps the biggest motivation was that the researchers
were aware of survivorship issues for women receiving
these treatments for cervical cancer and felt that “patient
involvement might be really helpful in getting to grips
with these issues.” The Patient Research Partners also
sensed that the systematic review was aiming to answer
questions about the treatments they had received;
“I wanted to know that I’d had the ‘right’ treatment” and
“I was pleased that someone was trying to address what
I perceived as the ‘gap’ once treatment was over. There
was a general lack of knowledge about late side effects
and that someone seemed to be trying to do something
about that felt like a good thing.”
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The Patient Research Partners were eager to use their
experiences to help with the research, “I was pleased to
be asked and felt that my experience could be of use as
someone who had recently been affected by cancer.”
What influence and impact did Patient Research Partners
have on this research?
Additional piece of research/editorial on patient
perspectives
Perhaps the greatest impact on the researchers of work-
ing with the Patient Research Partners was that it dir-
ectly led the researchers to get involved in another
research project with a greater focus on late side effects
of treatment. It also motivated them to publish an
editorial with the Patient Research Partners, discussing
the concerns of women after treatment for cervical
cancer [9]. The Patient Research Partners commented
that “being able to provide some information about late
effects and pulling together our thoughts on these
issues and getting both in print has been a great
achievement” and that, “the outcome passed my expec-
tations, as I witnessed how the team doing the evalu-
ation realized what information was missing and how
future trials could give more detailed and long term
information.”
Adding a viewpoint that otherwise would not have been
heard
The Patient Research Partners all agreed that their
main impact on the research was in adding a viewpoint
that otherwise would not have been heard, and reflect-
ing the concerns of women with cervical cancer by
contributing the opinions of “the normal woman off the
street.” They also felt that their involvement might help
to bring about changes, such that “hopefully future
trials will better collect data” on late side effects. One
Patient Research Partner did express concerns about
her involvement though, “For a meta-analysis where the
outcome measures have already been collected, I am
not sure how much difference we have really made
overall.”
Insight into cervical cancer and its treatment
The Patient Research Partners had also helped the
researchers to better understand cervical cancer and its
treatment, using their experience “to bring the results of
the study to life as it evidenced the experience of real
people.” The researchers felt the greatest impact of
involving the Patient Research Partners was the insight
they gained of the impact of cervical cancer, its treat-
ments and side effects, on the women’s day to day lives,
which would not have been possible without the Patient
Research Partner involvement.What aspects of Patient Research Partner involvement
worked well?
Recruitment
The Patient Research Partners felt that working with
charities like Jo’s Trust, which supports women with cer-
vical cancer (or similar groups for other disease areas),
was probably a very effective way to recruit patients, be-
cause the people who use them are, “very involved in
their disease and its treatment and will also potentially
have wider networks of people that they are in contact
with to draw experiences from.” Advertising the oppor-
tunity through CancerVoices was also felt to have been
an effective strategy by the researchers and Patient
Research Partners, because CancerVoices’ volunteers
have received training to help them to understand their
role in research and on effective meeting conduct. This
gives individuals more confidence in their role and what
may be expected of them. All agreed that having a small
group of Patient Research Partners had worked well, as
the group had felt balanced in terms of the numbers of
Patient Research Partners and researchers.
Information provision
The researchers had developed an information pack for
the Patient Research Partners (Additional file 2), which
was supported by presentations and discussions about
the project at meetings. On the whole, the Patient Re-
search Partners had found this useful and felt it was easy
to understand, providing them with the information they
needed without overloading them. “The presentations
and design of the materials took great care to unravel
the complex world of research acronyms and concepts
and explain complex ideas simply but without dumbing
down. That made me feel that we were equal partners in
a really important piece of work.”
Being of value
One of the key things from the Patient Research Part-
ners perspective was being made to feel that their contri-
bution was valued. One Patient Research Partner said “It
was also really pleasing that the hard work put into the
research project was recognized by the research commu-
nity and published. It’s a good feeling from a patient per-
spective to have contributed to a piece of work which
recognizes the after effects of treatment and survivorship
issues.”
Collaboration of researchers and patients
The Patient Research Partners said that overall they had
enjoyed being part of the team, learning about and gain-
ing insight into the research process, “We were part of a
shared experience of the scientific and patient communi-
ties working together to produce these outcomes, so it
felt like a collaborative venture. Quite often as a patient
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and it was really good to feel that our experience was
important and could help shape a piece of work in an
area where there was little info.”
Although there were some mixed feelings about their
participation at the Collaborators’ Meeting (see also sec-
tion What aspects of Patient Research Partner involve-
ment didn’t go so well?), at which results were presented
to the collaborative group for the first time, the Patient
Research Partners had mostly appreciated the opportun-
ity to attend, “the conference with senior practitioners
from all over the world was a very memorable experi-
ence for me. Understanding their priorities and their
perspective on cancer treatment was very revealing and
made the work with Patient Research Partners all the
more essential to help build a holistic picture of people
living with cancer and their needs.”
The Researchers felt that they learned a lot from the
Research Partners and in doing so, had overcome their
initial concerns and anxieties about involving Patient Re-
search Partners, such as being tokenistic and also about
discussing potentially “taboo” or sensitive subjects, “We
aren’t medical or nursing professionals so don’t have ex-
perience of working with patients. We had no idea how
well or poorly the women were going to be or whether
any of them were coming into it with preconceptions
that would make it difficult to work with them.” The
researchers felt that they had established good working
relationships with the Patient Research Partners and to-
gether, had achieved a lot.
What aspects of Patient Research Partner involvement
didn’t go so well?
It took a long time
One concern raised by the Patient Research Partners was
the length of time the project had taken. “The length of
time the research took was quite long, however I under-
stood that collating the information was not an easy task,
particularly when trying to locate trials in other countries
and getting the information from them”. One of the key
issues this raised was that as time passed, understandably,
one of the Patient Research Partners said that her “personal
interest in cancer has faded somewhat.”
Informed choices
Some comments and discussions at the Collaborators’
meeting had been difficult or upsetting for the Patient
Research Partners, “In the lead up to the Collaborators
meeting it would have been good to have been better
informed about the sorts of discussions that would take
place. . .that the clinicians are going to be blunt and sci-
entific in their approaches and not the normal ’bedside
manner’ we might be used to as patients!” All agreed
that it would be important to provide Patient ResearchPartners with more information about the potential na-
ture of discussions at the meeting to ensure that they
had the ability to make an informed choice about
attending the meeting and also to ensure that the clini-
cians attending the meeting knew that they were
patients. Furthermore, the Patient Research Partners felt
that there had been insufficient preparation regarding
what the results of the meta-analysis would look like.
This feedback led to a section being drafted and added
to the information pack, with the input of the Patient
Research Partners, to explain how meta-analysis results
are presented and what they mean.
Useful input?
Interestingly, one of the Patient Research Partners
expressed that she had concerns at the outset regarding
how much input ‘users’ could really make in the context
of a systematic review, given that the outcomes are to a
degree “pre-set by the outcomes that were collected
within the individual trials”. In this study, the protocol
development took place prior to Patient Research
Partners becoming involved, so it was felt that there
would be more opportunity for input if Patient Research
Partners had been involved earlier in the project. How-
ever, although the review aimed to evaluate treatment
side effects, it was not possible as suitable data were not
collected in all of the trials. One of the researchers
expressed that this had been disappointing, because it
“felt like we’d perhaps got the Research Partners
involved under false pretences and worried about what
they would get out of it because of the lack of data. With
hindsight we were perhaps overly optimistic about what
we could do.”
Resource implications
For this project, funding received through the UK De-
partment of Health (DoH) NCCRCD Evidence Synthesis
award scheme provided the resources to hold meetings,
pay the Research Partners for their time and reimburse
expenses. The researchers felt that this was important as
involving the Patient Research Partners had taken extra
time and effort; for example, the information pack had
taken some time to develop and produce. However, since
the information pack developed with the Research Part-
ners will form a template, similar information for future
projects may take considerably less time. The pressure
on researchers’ time only became an issue around key
points of the meta-analysis, “It was sometimes difficult
to bridge the needs and priorities of the Patient Research
Partners and the clinical/scientific collaborators.” In
addition, using the experience gained through this pro-
ject, the researchers felt that there would be less need
for an extensive Reference Group in subsequent pro-
jects, further reducing the resource requirement.
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and used to working together, it had been very easy to
involve them in the subsequent work around the draft-
ing of the editorial.What was learned about involving patients in future
IPDMAs?
Opportunity for real input
All of the Patient Research Partners said they would
consider getting involved in research again in the future.
“It was my first experience of user involvement and I
would certainly do it again if I felt that my experience
was relevant and could usefully contribute to research.”
However, one of the Patient Research Partners doubted
that she would get involved in another systematic re-
view, as she felt that there is more opportunity to shape
primary research. In future reviews, researchers felt that
Patient Research Partners should be involved at the stage
when the questions are being developed to give them
the opportunity to influence which outcomes should be
investigated. The researchers felt that they could only
commit to a similar approach to patient involvement for
systematic reviews based on IPD where there is resource
and perhaps as importantly, time, to train, support and
develop working relationships with patients. Other po-
tentially less resource-intensive models to involvement
could be adopted for standard systematic reviews. Also,
to ensure that Patient Research Partners were truly able
to influence the research, it was felt that involvement
should be prioritized for projects in which the outcomes
may be of most interest to patients and where patient in-
put might have the greatest impact on the research, for
example, survivorship issues, patient centered outcomes
or quality of life.Being selective about recruitment
The researchers were concerned about what they would
do if they received too many responses from interested
patients. One Patient Research Partner suggested that at
the outset, patients interested in becoming involved
could “attend an information session or meeting to see
what the project was about and understand the commit-
ment and what their role would be” before deciding to
participate. Patient Research Partners also thought it
would be appropriate for the researchers “to be selective
and only include people who can bring something to the
project.” All were in agreement that a small group (three
to five members) of Patient Research Partners had
worked well in this review and would be a good model
for the future. They also were enthusiastic about the idea
of mentors being provided for future Patient Research
Partners; for example, Patient Research Partners who
had already been involved in systematic reviews.Improved preparations for patient involvement
To overcome some of the difficulties experienced in this
review, future projects would need to set out realistic
time-lines at the outset, better inform the Patient
Research Partners about any delays to progress of the
project, provide better information about how the results
of meta-analyses are presented, and to better explain to
the Patient Research Partners about the format of the
Collaborators’ meeting, giving them the opportunity to
opt in or out.
Discussion
Our results describe the benefits and challenges of
researchers and patients carrying out systematic reviews
in partnership. The Patient Research Partners were
involved in three of the five main areas identified by
Boote and colleagues [5], namely, locating study investi-
gators, interpretation of the results from the patient per-
spective and writing an editorial on the findings of the
review and related research. We acknowledge that it
would have been preferable to involve patients at an
earlier stage to enable them to help define the scope of
the systematic review and would aim for this to be the
case for future meta-analyses of IPD conducted within
our group. While the Patient Research Partners were not
involved in appraising the studies identified for inclu-
sion, we tried to ensure that the reasons for collecting
and reanalyzing IPD in this review were well understood
and two of the Research Partners observed the process
of checking and managing incoming trial data.
Results of this evaluation are potentially limited in that
only three Patient Research Partners and two researchers
contributed to it. Also, there is a possibility that indivi-
duals may have held back some of their more negative
comments or concerns because the discussions were
open to all. However, the discussions were frank and
honest and the concerns of those involved were dis-
cussed fully. Furthermore, we cannot be certain how the
feelings of the Patient Research Partner who withdrew
from the project might have impacted on our results as
she did not complete an evaluation or provide her rea-
sons for withdrawing. Nevertheless, both the researchers
and Patient Research Partners thought that involvement
had been rewarding and worthwhile and all involved felt
they had learned from the experience. Good information
had been vital in helping the Patient Research Partners
to gain an understanding of the review and regular com-
munications were important in maintaining their inter-
est throughout the project. However, the project took a
long time to complete and with the benefit of hindsight,
they could have been better warned about this in ad-
vance. All of those involved felt that they would consider
involvement in future research projects; however, one
Research Partner was uncertain about involvement in
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and the potentially limited influence on the research.
However, despite this, highlighting gaps in the evidence
through a systematic review was felt by all to be
worthwhile.
In our setting of gynecological cancer, we were aware that
some of the issues were highly sensitive and, therefore, po-
tentially difficult to discuss. Furthermore, for recently trea-
ted patients, there is the possibility that the disease could
return or spread, making further involvement either prac-
tically or emotionally difficult, which researchers may need
to consider and plan for in advance. Different issues or
challenges may arise for reviews in different settings; for ex-
ample, when working with parents of sick children, people
with mental health problems or those with acute illness.
One of the benefits of systematic reviews using IPD
taking considerable time to complete is that researchers
and patients had time to develop good working relation-
ships and to gain an understanding of the process and
purpose of the research. Involvement of patients in this
systematic review and meta-analysis undoubtedly used
additional time and resources, which may be problem-
atic where reviews need to be conducted in a limited
timeframe or on restricted budgets. For standard sys-
tematic reviews using published results, where there
may be less opportunity for Patient Research Partners to
shape the research and more limited time in which to
complete the review, other approaches to involvement
may be more appropriate or more realistic; for example,
involving people with prior knowledge of the disease
and/or systematic reviews or engaging with established
patient groups and organizations. Alternatively, it may
be necessary to prioritize involvement in those projects
most likely to benefit from the input of patients; for ex-
ample, projects in which long-term side effects or quality of
life outcomes are key issues or in chronic or life-changing
diseases. In this project, specific funding allowed for the
payment of research partners, reimbursement of travel and
other expenses for meeting attendance and other overheads
associated and importantly, enabled researchers’ time to
be spent on involvement activities. We would strongly rec-
ommend that researchers planning to involve patients
in their research request additional resources in funding
applications.
Interestingly, Patient Research Partners were comfort-
able with the idea that researchers should be selective
about involvement. They felt that recruiting patients who
were in a good position to bring skills or ideas to the
group was acceptable and also understood that it might be
appropriate for researchers to consider what consumer in-
volvement might add to a specific systematic review and
to target involvement appropriately. While it was felt that
it had been quite resource intensive to establish a small
group of consumers to participate in the review, onceestablished, this model has a number of advantages. For
example, access to varied opinions, enabling almost imme-
diate involvement in follow-up or closely related research
projects and also the possibility of mentoring or helping in
the development of individuals in new research projects.
In the early stages of this project, there was little guid-
ance available to researchers on involving patients in sys-
tematic reviews. This meant that the Reference Group was
vital to facilitate patient involvement and to advise the
researchers. A similar model may benefit researchers com-
ing to patient involvement for the first time. Furthermore,
it may be helpful to seek advice from other researchers or
groups with experience of involving patients. New guid-
ance, led by a group of researchers and patients on behalf
of INVOLVE (www.INVO.org.uk), on patient and public
involvement in systematic reviews, is currently in develop-
ment and, once available, should help those embarking on
involving patients. We would certainly recommend that
reviewers also try to engage with a relevant patient group
or organization when embarking on a new review.
A recent review of published examples of patient in-
volvement in systematic reviews [5] found only seven
relevant examples across a broad spectrum of health and
social care research. Therefore, our evaluation provides
one of very few examples in the literature to date of
patient involvement in a systematic review and meta-
analysis, and perhaps the only example of involvement
in a systematic review based on individual patient data.
We would encourage reviewers who have involved
patients and the public in their reviews to report their
experiences in order that others may apply the lessons
learned by others in their own reviews.
Conclusions
This evaluation of patient involvement in a systematic re-
view and meta-analysis of individual patient data has
shown that patient involvement is possible and may bene-
fit the review process. Both the researchers and Patient
Research Partners found it to be a positive experience. It
does, however, require additional resources and careful
consideration should be given at the outset regarding the
reasons for involvement and its potential impact on the
individual review. A small group approach had a number
of advantages in this review; however, other approaches to
involvement may suit different types of review. Researchers
carrying out systematic reviews and involving patients or
the public in their reviews are encouraged to publish
their findings so that others may learn from their shared
experiences and to expand the evidence base for involve-
ment in reviews.
CEO, chief executive officer; DoH, Department of
Health (UK); IPD, individual patient data; NCCRCD,
National Coordinating Centre for Research Capacity
Development; RCTs, randomized controlled trials.
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